Switching from Intravenous to Subcutaneous Infliximab in Patients with Immune Mediated Diseases in Clinical Remission
N. Viazis,A. Karamanakos, K. Mousourakis,A. Christidou,F. Fousekis,K. Mpakogiannis, A. Koukoudis,K. Katsanos,D. Christodoulou, M. Cheila,M. Tzouvala,E. Zacharopoulou,M. Palatianou,O. Giouleme,A. Katsoula,C. Liatsos,N. Kyriakos,E. Zampeli,E. Papathanasiou,A. Theodoropoulou,K. Karmiris,I Psaroudakis,G. Tribonias, S. Gazi,E. Mole,T. Dimitroulas,C. Koutsianas,D. Vasilopoulos,G. Fragoulis, N. Michalakeas,C. Papagoras,P. Panagakis,M. Papoutsaki,V Chasapi,A. Stratigos,G. Katsikas JOURNAL OF CROHNS & COLITIS（2025）
关键词
ulcerrative colitis,Crohn disease,infliximab (ifx),spondyloarthritis,psoriatic arthritis,psoriasis
AI 理解论文
溯源树
样例
